Brief: Modus Therapeutics Q4 Loss After Tax Widens To SEK 12.3 Mln
22/02/2022 07:10
Feb 22 (Reuters) - Modus Therapeutics Holding AB MODTX.ST :
* Q4 LOSS AFTER TAX AMOUNTED TO TSEK 12 289 (1 019)
Source text for Eikon: ID:nWkr7G974T
Further company coverage: MODTX.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Modus Therapeutics Holding AB
See all newsBrief: Modus Therapeutics Temporarily Pauses Enrollment In Phase IIa Study Of Sevuparin In CKD With Anemia
Brief: Modus Gets SEK 0.13 Mln Through Exercise Of Warrants
Brief: Modus Therapeutics Resolves On Directed Share Issue Of 20 Million Shares
Sweden's Modus Therapeutics narrows Q2 net loss, extends financing
Brief: Modus Therapeutics Q2 Net Income SEK -4.645 Million